12490683

Source:http://linkedlifedata.com/resource/pubmed/id/12490683

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002679, umls-concept:C0537894, umls-concept:C1609535, umls-concept:C1707455
pubmed:issue	25
pubmed:dateCreated	2002-12-19
pubmed:abstractText	Caspofungin is an echinocandin agent with fungicidal activity against candida species. We performed a double-blind trial to compare caspofungin with amphotericin B deoxycholate for the primary treatment of invasive candidiasis.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12490683-12490691, http://linkedlifedata.com/resource/pubmed/commentcorrection/12490683-12660396, http://linkedlifedata.com/resource/pubmed/commentcorrection/12490683-12841719
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Amphotericin B, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antifungal Agents, http://linkedlifedata.com/resource/pubmed/chemical/Echinocandins, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic, http://linkedlifedata.com/resource/pubmed/chemical/caspofungin
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1533-4406
pubmed:author	pubmed-author:BettsRobertR, pubmed-author:Caspofungin Invasive Candidiasis Study Group, pubmed-author:ColomboArnaldo LopesAL, pubmed-author:KartsonisNicholasN, pubmed-author:LupinacciRobertR, pubmed-author:Mora-DuarteJorgeJ, pubmed-author:PerfectJohnJ, pubmed-author:RotsteinColemanC, pubmed-author:SableCaroleC, pubmed-author:SmietanaJuanitaJ, pubmed-author:Thompson-MoyaLuisL
pubmed:copyrightInfo	Copyright 2002 Massachusetts Medical Society
pubmed:issnType	Electronic
pubmed:day	19
pubmed:volume	347
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2020-9
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:12490683-APACHE, pubmed-meshheading:12490683-Adolescent, pubmed-meshheading:12490683-Adult, pubmed-meshheading:12490683-Aged, pubmed-meshheading:12490683-Aged, 80 and over, pubmed-meshheading:12490683-Amphotericin B, pubmed-meshheading:12490683-Anti-Bacterial Agents, pubmed-meshheading:12490683-Antifungal Agents, pubmed-meshheading:12490683-Candida, pubmed-meshheading:12490683-Candidiasis, pubmed-meshheading:12490683-Echinocandins, pubmed-meshheading:12490683-Female, pubmed-meshheading:12490683-Fungemia, pubmed-meshheading:12490683-Humans, pubmed-meshheading:12490683-Infusions, Intravenous, pubmed-meshheading:12490683-Male, pubmed-meshheading:12490683-Middle Aged, pubmed-meshheading:12490683-Neutropenia, pubmed-meshheading:12490683-Peptides, pubmed-meshheading:12490683-Peptides, Cyclic, pubmed-meshheading:12490683-Recurrence
pubmed:year	2002
pubmed:articleTitle	Comparison of caspofungin and amphotericin B for invasive candidiasis.
pubmed:affiliation	Neeman-ICIC and Hospital Mexico, C.C.S.S., San José, Costa Rica.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study